• Viktorija Tomič Bolnišnica Golnik Klinični oddelek za pljučne bolezni in alergijo 4204 Golnik
  • Petra Svetina-Šorli Bolnišnica Golnik Klinični oddelek za pljučne bolezni in alergijo 4204 Golnik
  • Darinka Trinkaus Bolnišnica Golnik Klinični oddelek za pljučne bolezni in alergijo 4204 Golnik
  • Jurij Šorli Bolnišnica Golnik Klinični oddelek za pljučne bolezni in alergijo 4204 Golnik
  • Andreas Widmer Divisions of Hospital Epidemiology University Hospitals Basel Switzerland
  • Andrej Trampuž Divisions of Hospital Epidemiology University Hospitals Basel Switzerland in Division of Infectious Diseases Department of Internal Medicine Mayo Clinic Rochester Minnesota USA
Keywords: MRSA, control, nosocomial infections


Background. This prospective cohort study presents the effectiveness and feasibility of a comprehensive control strategy to reduce nosocomial transmission of methicillinresistant Staphylococcus aureus (MRSA) in a highly endemic setting.

Methods. All patients with MRSA carriage admitted to the University Clinic of Respiratory and Allergic Diseases over a period of 5 years (January 1998 through December 2002) were included and categorized into imported or hospitalacquired cases. In January 1999, an aggressive infection control program was implemented. It was focused on promoting alcohol hand rub, obtaining active surveillance cultures for MRSA, implementing strict barrier precautions and decolonizing MRSA carriers.

Results. MRSA was recovered from 223 hospitalized patients; 142 cases were imported and 81 were acquired at our institution. After the introduction of an active surveillance program, the annual incidence of detected MRSA carriage per 1000 admissions first increased from 4.5 in 1998 to 8.0 in 1999 (p = 0.019), but remained stable thereafter. The proportion of patients detected through active surveillance cultures progressively increased from 23% in 1999 to 78% in 2002. Since 1999, the proportion of acquired MRSA cases in our institution has steadily decreased from 50% in 1999 to 6% in 2002 (p < 0.001), whereas the proportion of patients who acquired MRSA in other hospitals (p < 0.001) and nursing homes (p = 0.025) has increased.

Conclusions. With a comprehensive infection control program it is possible to substantially reduce nosocomial transmission of MRSA in a highly endemic area. With good hand hygiene, early detection, isolation and decolonization strategy, containment of MRSA is achievable despite a high rate of transferred patients colonized or infected with MRSA from other healthcare facilities.


Download data is not yet available.


Jevons MP. »Celebenin«-resistant staphylococci. Br Med J 1961; i: 124–5.

Ayliffe GA. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997; 24: Suppl 1: S74–S79.

Fluckiger U, Widmer AF. Epidemiology of methicillin-resistant Staphylococcus aureus. Chemotherapy 1999; 45: 121–34.

Wenzel RP, Reagan DR, Bertino JS Jr, Baron EJ, Arias K. Methicillin-resistant Staphylococcus aureus outbreak: a consensus panel’s definition and management guidelines. Am J Infect Control 1998; 26: 102–10.

Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13: 50–5.

Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001; 39: 3727–32.

Mishal J, Sherer Y, Levin Y, Katz D, Embon E. Two-stage evaluation and intervention program for control of methicillin-resistant Staphylococcus aureus in the hospital setting. Scand J Infect Dis 2001; 33: 498–501.

Blanc D, Pittet D, Ruef C et al. Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nation-wide survey in Switzerland. Swiss Med Wkly 2002; 132: 223–9.

Sax H, Pittet D. Interhospital differences in nosocomial infection rates: importance of case-mix adjustment. Arch Intern Med 2002; 162: 2437–42.

Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998; 27: 543–50.

Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999; 282: 1745–51.

Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53–9.

Engemann JJ, Carmeli Y, Cosgrove SE et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36: 592–8.

Kotilainen P, Routamaa M, Peltonen R et al. Eradication of methicillinresistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 2001; 161: 859–63.

Barrett SP, Mummery RV, Chattopadhyay B. Trying to control MRSA causes more problems than it solves. J Hosp Infect 1998; 39: 85–93.

Klavs I, Bufon-Luznik T, Skerl M et al. Prevalence of and risk factors for hospital-acquired infections in Slovenia – results of the first national survey, 2001. J Hosp Infect 2003; 54: 149–57.

Muzlovic I, Jereb M, Karner P, Voga G, Kaps R, Trampuz A. Prevalence study of nosocomial infections in intensive care units in Slovenia. 40th Annual Meeting of IDSA, October 24–27, 2002, Chicago, IL 2002; Abstract # 101258. Chicago: IDSA, 2002.

National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. NCCLS document M100–S12. National Committee for Clinical Laboratory Standards, Villanova, PA 2002.

Solberg CO. Spread of Staphylococcus aureus in hospitals: causes and prevention. Scand J Infect Dis 2000; 32: 587–95.

Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36: 131–9.

Boyce JM. Consequences of inaction: importance of infection control practices. Clin Infect Dis 2001; 33: Suppl 3: S133–S7.

Harbarth S, Pittet D. Control of nosocomial methicillin-resistant Staphylococcus aureus: where shall we send our hospital director next time? Infect Control Hosp Epidemiol 2003; 24: 314–6.

Widmer AF. Replace hand washing with use of a waterless alcohol hand Rub? Clin Infect Dis 2000; 31: 136–43.

Herwaldt LA. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am J Med 1999; 106: 11S–8S.

Harbarth S, Martin Y, Rohner P, Henry N, Auckenthaler R, Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillinresistant Staphylococcus aureus. J Hosp Infect 2000; 46: 43–9.

Monnet DL, Frimodt-Moller N. Antimicrobial-drug use and methicillinresistant Staphylococcus aureus. Emerg Infect Dis 2001; 7: 161–3.

How to Cite
Tomič V, Svetina-Šorli P, Trinkaus D, Šorli J, Widmer A, Trampuž A. CONTROL OF NOSOCOMIAL SPREAD OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA). ZdravVestn [Internet]. 1 [cited 22Sep.2019];72(12). Available from:
Professional Article